Kate Hsu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kate Hsu

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

The Journal of Clinical Endocrinology and Metabolism|November 5, 2023

Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease ActivityRaymond S Douglas, Steven Couch, Sara T Wester, et al.

Molecular Medicine (Cambridge, Mass.)|June 14, 2024

The implication of serum HLA-G in angiogenesis of multiple myelomaChi Wang, Nai-Wen Su, Kate Hsu, et al.

Asia-Pacific Journal of Clinical Oncology|March 31, 2022

Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trialJihong Liu, Rutie Yin, Lingying Wu, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

The Journal of Clinical Endocrinology and Metabolism|November 5, 2023

Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease ActivityRaymond S Douglas, Steven Couch, Sara T Wester, et al.

Molecular Medicine (Cambridge, Mass.)|June 14, 2024

The implication of serum HLA-G in angiogenesis of multiple myelomaChi Wang, Nai-Wen Su, Kate Hsu, et al.

Asia-Pacific Journal of Clinical Oncology|March 31, 2022

Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trialJihong Liu, Rutie Yin, Lingying Wu, et al.

Pageof 4